跳至主要内容
临床试验/NCT04224896
NCT04224896已完成不适用

Narrow-Band Imaging (NBI) Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population: a Randomised Controlled Multicentre Trial

Hôpital Edouard Herriot0 个研究点目标入组 335 人开始时间: 2011年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
335
主要终点
SPECIFICITY OF THE TWO DIAGNOSTIC STRATEGIES

研究概览

简要总结

Narrow-Band Imaging (NBI) is as sensitive as Lugol chromoendoscopy to detect oesophageal squamous cell carcinoma (SCC) and appears more specific than Lugol chromoendoscopy in expert centres but its specificity in current practice is not known. This study aimed to prove the superiority of NBI specificity over Lugol chromoendoscopy to detect oesophageal SCC and high-grade dysplasia (HGD) in current practice (including tertiary care centres, local hospitals and private clinics).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients had a history or current SCC

排除标准

  • 未提供

结局指标

主要结局

SPECIFICITY OF THE TWO DIAGNOSTIC STRATEGIES

时间窗: 4 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jean Christophe Saurin

Professor

Hôpital Edouard Herriot

相似试验